SUMMIT THERAP

SMMT NASDAQ
1.295
-0.051
-3.78%
已收盘, 16:00 07/17 EDT
开盘
1.320
昨收
1.346
最高
1.383
最低
1.295
成交量
9,634
成交均量(3M)
4.17万
52周最高
2.680
52周最低
1.100
换手率
0.03%
市值
4,156.17万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供SUMMIT THERAP SMMT股票价格,SUMMIT THERAP股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Summit Therapeutics plc is a biopharmaceutical company, which is engaged in drug development. The Company is focused on the discovery, development and commercialization of medicines for indications for which there are no existing or only inadequate therapies. It is conducting clinical programs focused on the infectious disease Clostridium difficile infection (CDI). Its lead CDI product candidate is ridinilazole, which is an orally administered small molecule antibiotic. Its Ridinilazole is in Phase II clinical trials. It has conducted over three Phase I clinical trials of ezutromid.
展开 >

最近浏览

名称
价格
涨跌幅